NMUS - Nemus Bioscience, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development57.865636.621333.364166.764
Selling General and Administrative3,801.3643,833.9593,983.7462,564.897
Non Recurring----
Others----
Total Operating Expenses3,859.2294,470.584,317.112,731.661
Operating Income or Loss-3,859.229-4,470.58-4,317.11-2,731.661
Income from Continuing Operations
Total Other Income/Expenses Net766.5311,294.087-522.335-
Earnings Before Interest and Taxes-3,859.229-4,470.58-4,317.11-2,731.661
Interest Expense-0.667-0.667-0.667-0.667
Income Before Tax-3,092.698-3,176.493-4,839.445-2,731.661
Income Tax Expense1.61.61.7162.505
Minority Interest----
Net Income From Continuing Ops-3,094.298-3,178.093-4,841.161-2,734.166
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-3,094.298-3,178.093-4,841.161-2,734.166
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-4,138.298-3,503.093-4,841.161-2,734.166